Abstract
The Pak4 serine/threonine kinase is highly expressed in many cancer cell lines and human tumors. Although several studies have addressed the role for Pak4 in transformation of fibroblasts, most human cancers are epithelial in origin. Epithelial cancers are associated not only with changes in cell growth but also with changes in the cellular organization within the three-dimensional (3D) architecture of the affected tissues. In this study we used immortalized mouse mammary epithelial cells (iMMECs) as a model system to study the role for Pak4 in mammary tumorigenesis. iMMECs are an excellent model system for studying breast cancer, as they can grow in 3D-epithelial cell culture, in which they form acinar structures that recapitulate in vivo mammary morphogenesis. Although Pak4 is expressed at low levels in wild-type iMMECs, it is overexpressed in response to oncogenes, such as oncogenic Ras and Her2/neu. In this study we found that overexpression of Pak4 in iMMECs leads to changes in 3D acinar architecture that are consistent with oncogenic transformation. These include decreased central acinar cell death, abrogation of lumen formation, cell polarity alterations and deregulation of acinar size and cell number. Furthermore, iMMECs overexpressing Pak4 form tumors when implanted into the fat pads of athymic mice. Our results suggest that overexpression of Pak4 triggers events that are important for the transformation of mammary epithelial cells. This is likely to be owing to the ability of Pak4 to inhibit apoptosis and promote cell survival and thus subsequent uncontrolled proliferation, and to its ability to deregulate cell shape and polarity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abo A, Qu J, Cammarano MS, Dan C, Fritsch A, Baud V et al. (1998). PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J 17: 6527–6540.
Callow MG, Clairvoyant F, Zhu S, Schryver B, Whyte DB, Bischoff JR et al. (2002). Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J Biol Chem 277: 550–558.
Chandramouly G, Abad PC, Knowles DW, Lelievre SA . (2007). The control of tissue architecture over nuclear organization is crucial for epithelial cell fate. J Cell Sci 120: 1596–15606.
Chen S, Auletta T, Dovirak O, Hutter C, Kuntz K, El-Ftesi S et al. (2008). Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification. Cancer Biol Ther 7: 1793–1802.
Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS . (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111: 29–40.
Debnath J, Muthuswamy SK, Brugge JS . (2003). Morphogenesis and oncogeesis of MCF-10A mammary epithelial acini grown in thre-dimensional basement membrane cultures. Methods 30: 256–268.
Degenhardt K, White E . (2006). A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res 12: 5298–5304.
Gnesutta N, Minden A . (2003). Death Receptor Induced Activation of Initiator Caspase-8 is Antagonized by the Serine/Threonine Kinase PAK4. Mol Cell Biol 23: 7838–7848.
Gnesutta N, Qu J, Minden A . (2001). The Serine/Threonine Kinase PAK4 prevents caspase activation and protects cells from apoptosis. J Biol Chem 276: 14414–14419.
Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S et al. (2007). Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes and Development 21: 1621–1635.
Karantza-Wadsworth V, White E . (2008). A mouse mammary epithelial cell model to identify molecular mechanisms regulating breast cancer progression. Meth Enzymol 446: 61–76.
Kimmelman AC, Hezel AF, Aguirre AJ, Zheng H, Paik JH, Ying H et al. (2008). Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 105: 19372–19377.
Konska G, Guillot J, De Latour M, Fonck Y . (1998). Expression of Tn antigen and N-acetyllactosamine residues in malignant and benign human breast tumors detected by lectins and monoclonal antibody 83D4. Int J Oncol 12: 361–367.
Li X, Minden A . (2005). PAK4 functions in tumor necrosis factor (TNF) alpha-induced survival pathways by facilitating TRADD binding to the TNF receptor. J Biol Chem 280: 41192–41200.
Liu Y, Xiao H, Tian Y, Nekrasova T, Hao X, Lee HJ et al. (2008). The Pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol Cancer Res 6: 1215–1224.
Moreno-Bueno G, Portillo F, Cano A . (2008). Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27: 6958–6969.
Muthuswamy S, Li D, Lelievre S, Bissell M, Brugge JS . (2001). ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nature Cell Biol 3: 785–792.
Paliouras GN, Naujokas MA, Park M . (2009). Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol Cell Biol 29: 3018–3032.
Qu J, Cammarano MS, Shi Q, Ha KC, de Lanerolle P, Minden A . (2001). Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol Cell Biol 21: 3523–3533.
Tanos B, Rodriguez-Boulan E . (2008). The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 27: 6939–6957.
Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME . (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326–1331.
Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB et al. (2008). Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135: 865–878.
Acknowledgements
We thank Dr Chung S Yang and Dr Zhihong Yang for providing human colon cancer cell lines. This work was supported by R01 CA076342 to AM and R00 CA133181 to VK.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Liu, Y., Chen, N., Cui, X. et al. The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis. Oncogene 29, 5883–5894 (2010). https://doi.org/10.1038/onc.2010.329
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.329
Keywords
This article is cited by
-
Baicalein Inhibits the Growth of Transplanted Esophageal Cancer in Mice and the Effect on the Expression of PAK4
Bulletin of Experimental Biology and Medicine (2023)
-
Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases
Cancer and Metastasis Reviews (2020)
-
A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERα-positive breast cancer cells
Oncogene (2019)
-
Molecular and Transcriptional Signatures for ErbB2-Induced Invasion
Current Pharmacology Reports (2019)
-
Inhibitors of the p21 Activated Kinases
Current Pharmacology Reports (2018)